Oura and Stelo alongside the mobile app. [Image courtesy of Dexcom/Oura]Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with Stelo.
Stelo, the company’s FDA-cleared over-the-counter (OTC) glucose biosensor, now gives users 24/7 glucose insights via the Oura app. Oura’s new in-app metabolic health feature, Glucose, now gives Oura members a deeper understanding of how dietary choices impact health. It provides nutrition and glucose data directly from Stelo in the context of sleep, activity, stress and more.
Dexcom and Oura plan to make the new health feature available in the Oura Ring app for all U.S. members.
This latest development builds on a partnership first struck between the companies last fall. The partnership aims to help people improve their metabolic health by integrating Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from the Oura Ring. Combining glucose data with biometrics can deliver a more complete picture of overall health to users. It led to a $200 million fundraising round for Oura, led by Dexcom.
Dexcom says the first-to-market glucose biosensor and smart ring integration can deliver a one-of-a-kind, personalized health experience. It should allow users to better understand links between activity, sleep, stress, nutrition and their glucose.
The app can help them learn lifestyle habits to achieve optima glucose balance. Meanwhile, the companies introduced a new key metric through the Glucose screen — “Time Above Range.” This refers to time spent above their target glucose range and provides an AI-powered analysis of glucose trends for that day.
More about the offerings through this product integration
The new offering from Dexcom and Oura includes the Meals feature. By taking a picture, members can log their food and see how effectively their meals and snacks fuel them through AI-powered food recognition.
A man sleeps while wearing the Stelo CGM and Oura Ring. [Image courtesy of Dexcom/Oura]Beyond that, with the Glucose feature, Oura members can purchase Stelo direclty from Oura’s website to receive their glucose insights. It leverages the OTC sensor’s accurate glucose sensing technology to reveal how lifestyle factors can affect glucose.
It designed Stelo, a small, wearable sensor, specifically for people with type 2 diabetes who do not use insulin. Worn on the back of the arm, the sensor provides insights directly to a user’s smartphone. Stelo features a 15-day wear based on the G7 platform. It offers a software experience tailored specifically for non-insulin users. The company said it makes it easier for the target population to access CGM and offers an option for those who don’t have insurance coverage for CGM.
(CEO Kevin Sayer spoke to Drug Delivery Business News about the next steps for Stelo at ADA 2024 — read about it here.)
The Meals and Glucose features join Oura’s suite of offerings powered by its AI-powered health coach, Oura Advisor. It gives members personalized, contextual and empathetic guidance. The coach can also asnwer general health questions or guide and support users to make changes that align with their health goals.
Commentary from Dexcom and Oura officials
Dexcom EVP and COO Jake Leach said:
“Personalized guidance and insights are essential for helping people understand how their lifestyle choices affect their body, while also encouraging them to make informed health decisions that can improve their overall quality of life,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “By integrating with ŌURA, we’re bringing the first glucose biosensor and smart ring integration to the market, providing a one-of-a-kind and personalized metabolic health experience that allows users to better understand the link between activity, sleep, stress, nutrition, and their glucose. Through this partnership, we’re once again redefining the wearable technology category in the pursuit of empowering people to take control of their health.”
An Oura ring user looks at glucose values on the app. [Image courtesy of Dexcom/Oura]
Oura Chief Product Officer Holly Shelton said:
“Our product roadmap for this year is built on a robust investment in AI-forward offerings that enable a deeper understanding of the dynamic interplay of key health factors,” said Holly Shelton, chief product officer at ŌURA. “The addition of nutrition-focused features to our product experience was a natural next step, especially considering how personal diet—and its impact on health—can be. Our bodies all process food in different ways, which is why we’re leveraging a unique combination of ŌURA’s extensive biometric tracking, generative AI, and Stelo glucose data to address a critical need for more individualized and accessible metabolic health solutions. By integrating nutrition information with activity, stress, and sleep, we’re empowering members with a deeper understanding of how their daily habits influence their wellbeing.”
Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.
